CureVac NV said Wednesday its experimental Covid-19 vaccine was 47% effective against the disease in an interim analysis of a large clinical trial, a disappointing outcome likely to dim the shot's prospects for wider use.
The setback could hinder vaccination campaigns in Europe because the German company has a contract with the European Commission to supply up to 405 million doses. CureVac has struck partnerships with big pharmaceutical companies GlaxoSmithKline PLC and Novartis AG to help make doses.
Israel-Hamas Tensions High as Gaza Militants Launch More Flaming Balloons
TEL AVIV-Palestinian militants in Gaza launched more flaming balloons into Israel on Wednesday, as a new round of violence between Israel and Hamas entered a second day and threatened to trigger another conflict.
Little-known militant groups in Gaza claimed responsibility for the arson attacks, which ignited four fires in agricultural zones in southern Israel, according to Israel's Fire and Rescue Authority.
Regeneron's Antibody Drug Cuts Risk of Death in Some Covid-19 Patients
An antibody treatment developed by Regeneron Pharmaceuticals Inc. has been shown to significantly cut the risk of death among certain hospitalized Covid-19 patients, raising hopes for a valuable new tool for tackling severe cases.
A large U.K. trial involving nearly 10,000 patients showed that administering REGEN-COV on top of usual care reduced the risk of dying by a fifth among hospitalized coronavirus patients who hadn't produced antibodies to the virus. The drug had no effect among patients who had already produced antibodies.
Write to firstname.lastname@example.org
Expected Major Events for Thursday
04:30/NED: May Unemployment
06:00/EU: May New Passenger Car Registrations in Europe statistics (EU27 + EFTA3)
06:00/SWI: May Trade Balance
07:00/SVK: May Harmonized CPI
07:00/AUT: May CPI
07:00/SPN: Apr Trade Balance
07:30/SWE: 1Q Financial accounts
07:30/SWI: Swiss National Bank monetary policy assessment
08:00/ITA: Apr Foreign Trade EU
08:00/NOR: Norges Bank monetary policy decision and presentation of Monetary Policy Report
09:00/MLT: May Harmonised CPI
09:00/EU: May Harmonised CPI
09:00/EU: Apr Construction output
11:00/TUR: Turkish interest rate decision
All times in GMT. Powered by Kantar Media and Dow Jones.
Write to us at email@example.com
We offer an enhanced version of this briefing that is optimized for viewing on mobile devices and sent directly to your email inbox. If you would like to sign up, please go to https://newsplus.wsj.com/subscriptions.
This article is a text version of a Wall Street Journal newsletter published earlier today
(END) Dow Jones Newswires